Skip to main navigation
  • Recent News
  • Investors
  • Contact Us
Avadel pharmaceutical logo
  • Home
  • Our Focus
  • Culture & Careers
  • Recent News
  • Investors
  • Contact Us

Breadcrumb

  1. Home
  2. Investors
  3. Erick J. Ende, M.D.

Biography

« Back
Eric J. Ende M.D.
Director
Dr. Eric J. Ende has been a member of the Avadel Board of Directors since December of 2018. Eric currently serves as President of Ende BioMedical Consulting Group and as a member of Matinas BioPharma’s Board of Directors. Eric’s previous roles including serving on the Board of Progenics from 2019 until 2020 when it was acquired by Lantheus Holdings, and serving on the Board of Directors of Genzyme from 2010 until it was acquired by Sanofi-Aventis in 2011 for $20 billion. During his tenure on Genzyme's Board of Directors, Eric was a member of the Audit and Risk Management Committees. Prior to acting as a Board Member for Genzyme, Dr. Ende acted as a biotechnology analyst, previously serving at Merrill Lynch, Bank of America Securities, and Lehman Brothers. Eric received undergraduate degrees from Emory University, his MD from the Icahn School of Medicine at Mount Saini, and an MBA from NYU Stern School of Business.
Financial Expert
  • Member of the Audit Committee
  • Chair of the Nominating and Corporate Governance Committee

Tools

  • Print Page
  • RSS
  • E-mail Alerts

Investor Relations

  • Investors
  • News & Events
    • Press Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Financial Information
    • SEC Filings
    • Financial Reports
    • Quarterly Results
  • Corporate Governance
    • Governance Highlights
    • Management Team
    • Board of Directors
    • Committee Composition
    • Annual General Meeting
  • Shareholder Services
    • Investor FAQs
    • Information Request
    • E-mail Alerts
    • IR Contacts
  • Our Focus
  • Culture & Careers
  • Investors
  • Recent News
  • Contact Us
  • Home
  • Our Focus
  • Culture & Careers
  • Contact Us
  • Recent News
  • Investors
  • Privacy Policy
  • Corporate Compliance
  • Terms and Conditions

The Avadel logo, the droplet brand mark, and other brands are trademarks of an Avadel company. © 2022 Avadel. All rights reserved.

PM-US-AVGEN-0115

We Care About Your Privacy

This website uses cookies. By using our website without changing your cookie settings, you agree to our use of cookies as described in our updated Privacy Policy.

You are about to leave the Avadel website.

Do you want to continue?

Avadel is not responsible for the content or availability of third party sites.